MedPath

FLUMIST

FLUMIST

Approved
DIN Number

02352621

Drug Class

Human

Market Date

N/A

Company
HC

astrazeneca canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02352621
AIG Number0352747003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BB03 INFLUENZA, LIVE ATTENUATED
Product Specifications
Dosage FormSpray
Route of AdministrationNasal
AHFS Classification80:12.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

INFLUENZA VIRUS TYPE A (H1N1)Active
Strength: 32000000 FFU / 0.2 ML
Monograph: INFLUENZA VIRUS TYPE A (H1N1)
INFLUENZA VIRUS TYPE A (H3N2)Active
Strength: 32000000 FFU / 0.2 ML
Monograph: INFLUENZA VIRUS TYPE A (H3N2)
INFLUENZA VIRUS TYPE BActive
Strength: 32000000 FFU / 0.2 ML
Monograph: INFLUENZA VIRUS TYPE B

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.